CVRX 9.69 CVRx, Inc.
| Range: | 6.4-33.135 | Vol Avg: | 269340 | Last Div: | 0 | Changes: | 1.39 |
| Beta: | 1.21 | Cap: | 0.21B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Wed Jun 30 2021 | Empoloyees: | 200 | ||
| CUSIP: | 126638105 | CIK: | 0001235912 | ISIN: | US1266381052 | Country: | US |
| CEO: | Mr. Kevin Hykes | Website: | https://www.cvrx.com | ||||
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Stock Details
CVRX 14
Cantor starts CVRx with Overweight on heart failure potential
Ross Osborn·Tue Sep 10 2024
Cantor Fitzgerald
CVRX 13
CVRx price target lowered to $13 from $15 at Piper Sandler
Matt O'Brien·Tue Jul 30 2024
Piper Sandler
CVRX 15
CVRx Inc (CVRX) PT Raised to $15 at Canaccord Genuity
William Plovanic·Tue Jul 30 2024
Canaccord Genuity
CVRX 12
CVRx price target lowered to $12 from $18 at Lake Street
Frank Takkinen·Thu Jul 11 2024
Lake Street
CVRX 18
CVRx Inc (CVRX) PT Lowered to $18 at Lake Street Capital Markets
Frank Takkinen·Wed Jun 05 2024
Loop Capital Markets
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow